INNOGENE Decides on 20% Dilutive Third-Party Allotment with 1-Year Lock-up and Potential Management Change

INNOGENE has decided on a third-party allotment of 2.4 million new shares, representing approximately 20% dilution of existing shares, to raise 3.36 billion KRW for operating funds.
The new shares are issued at 1,400 KRW, a 14% premium to the reference price, and all shares will be subject to a 1-year lock-up. Although the issue price exceeds the current market price of 1,275 KRW, the dilution effect remains substantial.
Allottees are Jeong Ki-cheol 120,000 shares and MetaMorphosis Co., Ltd. 2,280,000 shares. Upon payment, the allottees may request equal board representation and a co-CEO, indicating a potential change in management control.
[AI Summary]This capital increase results in significant dilution of approximately 20% for existing shareholders. Despite the premium issue price, the large dilution and potential management change introduce downside risk and uncertainty for the stock price in the near term.